Neurostar USA
North America Distributor of NeuroStar® Stereotaxic Robots
MuriPhys is a neuroscience-focused translational research company dedicated to advancing central nervous system (CNS) drug delivery and preclinical innovation. Built on a foundation of rigorous in vivo methodology, surgical precision, and translational insight, we specialize in enabling biotechnology and pharmaceutical partners to move CNS therapeutics forward with confidence.
Today, we are proud to expand our impact as the official North America distributor of NeuroStar® stereotaxic robotic systems—bringing world-class precision neurosurgical technology directly to research institutions, biotechnology companies, and preclinical laboratories across the United States and Canada.
Our Foundation: CNS Delivery Excellence
At the core of MuriPhys is a deep expertise in CNS-targeted delivery and biodistribution science. Our internal development programs have focused on validating and optimizing stereotaxic injection methods for the brain, including intra-striatal, intra-cerebellar, intra-cisterna magna, and intra-cerebroventricular approaches .
These efforts were formalized under our Preclinical Development Protocol NPS-24-01, designed specifically to evaluate and refine our internal CNS drug delivery capabilities. In these studies, we utilized recombinant AAV systems to characterize biodistribution and transduction efficiency in rodent models-work that requires highly reproducible and precise stereotaxic targeting.
Central to this capability has been the NeuroStar® robotic stereotaxic system. Across multiple preclinical protocols, injections were performed using the Robot Stereotaxic system from NeuroStar (Tübingen, Germany). The system has been used to execute highly accurate injections at defined AP, ML, and DV coordinates relative to Bregma-a level of precision essential for CNS biodistribution studies and therapeutic validation.
Our experience using NeuroStar robotics in active preclinical CNS delivery programs uniquely positions MuriPhys not just as a distributor-but as a true technical authority.
Why NeuroStar® Robotics?
Modern CNS therapeutic development demands:
- Sub-millimeter targeting accuracy
- Reproducibility across operators
- Reduced variability in surgical technique
- Integration with complex injection paradigms
- Scalability from feasibility studies to GLP-enabling work
The NeuroStar® robotic stereotaxic platform delivers on these requirements. In our own internal validation studies, NeuroStar systems have been used to perform bilateral stereotaxic injections into the striatum and other brain regions, supporting biodistribution analyses through immunofluorescence and molecular imaging.
Because our team has implemented these systems within real CNS drug development workflows-not just demonstrations-we understand how critical reliability, calibration, workflow integration, and technical support are to research success. This operational experience informs everything we do as a distributor.
From End-User to Strategic Partner
Our journey with NeuroStar technology began as end users—scientists developing CNS delivery platforms and validating reporter AAV biodistribution models.
Through extensive use in preclinical models—including striatal injections and multi-site targeting paradigms-we developed not only procedural mastery but a deep understanding of how robotic stereotaxic precision impacts downstream data quality, variability, and translational confidence.
This direct operational experience distinguishes MuriPhys from traditional equipment distributors.
We do not simply supply hardware-we:
- Understand stereotaxic surgery in active CNS drug programs
- Support integration into preclinical workflows
- Advise on injection paradigms and coordinate strategies
- Provide insight into experimental design considerations
- Offer training grounded in real-world application
As a North America distributor, our mission is to elevate how robotic stereotaxy is adopted, implemented, and optimized across the neuroscience research ecosystem.
Supporting the Next Generation of CNS Therapeutics
CNS-targeted gene therapies, RNA-based therapeutics, viral vectors, biologics, and neuromodulatory approaches all rely on precise anatomical targeting. In our internal programs evaluating AAV5 and AAV9 biodistribution in CNS delivery, stereotaxic accuracy was fundamental to interpreting transduction patterns and validating therapeutic feasibility.
Reporter studies are foundational in preclinical CNS research because they allow investigators to track and quantify where and how therapeutics travel within the brain. Without precision in delivery, biodistribution data becomes confounded by variability in targeting.
NeuroStar robotic systems provide:
- Automated coordinate targeting
- High reproducibility across animals
- Reduced manual drift
- Enhanced confidence in experimental interpretation
By distributing NeuroStar systems throughout North America, MuriPhys is enabling institutions and biotech companies to strengthen the foundation of their CNS programs.
What We Offer as a Distributor
As the North America distributor of NeuroStar® stereotaxic robots, MuriPhys provides:
1. System Sales & Installation
Full support from procurement through installation and system validation.
2. Scientific Training
Hands-on instruction grounded in active CNS delivery protocols, including multi-site targeting strategies.
3. Workflow Integration Consulting
Guidance on implementing robotic stereotaxy into preclinical biodistribution studies, vector validation programs, and translational CNS research workflows.
4. Ongoing Technical Support
Backed by a team that actively operates NeuroStar systems in CNS research environments.
5. Strategic Advisory
Support for biotech companies building CNS platforms who require not only hardware—but precision surgical infrastructure.
A Shared Commitment to Precision
The future of neuroscience depends on precision.
Precision in delivery.
Precision in targeting.
Precision in data generation.
Precision in translation.
Our internal CNS development programs have demonstrated how robotic stereotaxy directly contributes to high-quality biodistribution and delivery validation studies. We have used NeuroStar systems to execute complex injection paradigms across multiple brain regions and defined stereotaxic coordinates for striatal targeting.
This experience drives our confidence in the technology—and our commitment to bringing it to the broader North American research community.
Expanding Access Across North America
By serving as the North America distributor for NeuroStar®, MuriPhys ensures:
- Faster access to robotic stereotaxic systems
- Localized technical expertise
- Reduced procurement complexity
- Scientific partnership beyond equipment delivery
We believe that cutting-edge neuroscience tools should be supported by teams who understand both the hardware and the biology.
Our role is not transactional-it is translational.
Our Vision
MuriPhys was founded to accelerate CNS therapeutic development by combining surgical precision, translational neuroscience, and operational excellence. Becoming the North America distributor of NeuroStar® robotics represents a natural extension of that mission.
We are not only users of robotic stereotaxy—we are advocates for its transformative impact on CNS research. By empowering laboratories with advanced stereotaxic automation, we aim to:
- Reduce variability in preclinical data
- Improve reproducibility across studies
- Strengthen translational confidence
- Support innovation in gene therapy and beyond
Partner With Us
Whether you are:
- A biotechnology company building a CNS gene therapy platform
- An academic laboratory expanding neurosurgical capabilities
- A translational research group seeking reproducible delivery systems
- A CRO enhancing precision injection services
MuriPhys is your trusted North America partner for NeuroStar® stereotaxic robotics. We bring more than distribution—we bring experience, integration expertise, and a shared commitment to advancing neuroscience.
MuriPhys
Advancing CNS Precision.
Now delivering NeuroStar® Robotics across North America.
